Findings GLP-1 receptor agonists and dual incretin agonists exert their therapeutic effects through multiple mechanisms, including enhancement of glucose-dependent insulin secretion, suppression of glucagon release, appetite reduction, and slowing of gastric emptying
It's important to note that while Wegovy (semaglutide 2.4 mg) is approved for weight management, Ozempic (semaglutide) is FDA-approved only for type 2 diabetes treatment, not for weight loss
Eriomin contains citrus flavonoids shown to support antioxidant activity, modulate inflammation, potentially increase GLP-1 by up to 22% and improve fasting blood glucose over time (6)
These drugs were originally designed to support people with type 2 diabetes, helping regulate blood sugar
How to perform vitamin Shots (Training Video Link) Firstly, clean the top of the Lipo-Mino vial with provided alcohol swab